Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Feb 18, 2021 · 10-Q · 49 days after period end · 0001740797-21-000005
| Metric | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Net Income | -$417.16K | -$10.17K | -$19.01K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 18, 2021 · 49 d after period end
